Please login to the form below

Not currently logged in
Email:
Password:

Thomas Lonngren

This page shows the latest Thomas Lonngren news and features for those working in and with pharma, biotech and healthcare.

EMA to stop ‘revolving doors’ committee members

EMA to stop ‘revolving doors’ committee members

Thomas Lönngren took up a new post at the European regulatory and market access firm the NDA Group, just weeks after leaving his position.There were also allegations that he had ... Under these new rules, Lönngren would have had to have stepped away

Latest news

  • Data transparency in Europe Data transparency in Europe

    This is a much different attitude to its former executive director Thomas Lonngren, who through his long tenure at the EMA blocked the active disclosure of data, saying it would affect ... In December 2010 Lonngren left the Agency to work for the NDA

  • Pharma's biggest news stories in 2011

    A new head for the EMA was also appointed following Thomas Lonngren's departure in December, 2010, with former director-general of the Italian Medicines Agency, Guido Rassi, finally taking over ... Lonngren found himself in the news again rather recently

  • Ex-head of EMA "set up consultancy while still in office"

    Thomas Lonngren faces criticism from transparency pressure groups. The former head of the European Medicines Agency (EMA), Thomas Lonngren, is facing criticism for setting up a consultancy business to advise ... The groups maintain that Lonngren's actions

  • Andreas Pott appointed deputy director at the European Medicines Agency

    Pott has spent the last 11 months as the European regulator's acting executive director while it conducted a protracted search for a permanent candidate following the departure of Thomas Lonngren

  • New EMA executive director Guido Rasi takes office

    Rasi replaces Thomas Lonngren, who left the European Medicines Agency in December last year. ... The European drugs regulator has been without an executive director since December last year following the departure of Thomas Lonngren and has struggled to

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics